Pulse Biosciences Stock Forecast, Price & News

Pulse Biosciences (NASDAQ:PLSE) Frequently Asked Questions

Is Pulse Biosciences a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Pulse Biosciences stock.
View analyst ratings for Pulse Biosciences or view top-rated stocks.

How has Pulse Biosciences' stock been impacted by Coronavirus?

Pulse Biosciences' stock was trading at $6.36 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, PLSE shares have increased by 214.3% and is now trading at $19.99.
View which stocks have been most impacted by COVID-19.

When is Pulse Biosciences' next earnings date?

Pulse Biosciences is scheduled to release its next quarterly earnings announcement on Monday, February 28th 2022.
View our earnings forecast for Pulse Biosciences.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc. (NASDAQ:PLSE) posted its quarterly earnings data on Monday, November, 15th. The company reported ($0.48) EPS for the quarter, topping the consensus estimate of ($0.53) by $0.05. During the same quarter in the previous year, the business posted ($0.51) earnings per share.
View Pulse Biosciences' earnings history.

What price target have analysts set for PLSE?

3 equities research analysts have issued 12 month target prices for Pulse Biosciences' shares. Their forecasts range from $28.00 to $43.00. On average, they anticipate Pulse Biosciences' stock price to reach $37.00 in the next year. This suggests a possible upside of 85.1% from the stock's current price.
View analysts' price targets for Pulse Biosciences or view top-rated stocks among Wall Street analysts.

Who are Pulse Biosciences' key executives?

Pulse Biosciences' management team includes the following people:

• Darrin R. Uecker, President, Chief Executive Officer & Director
• Edison Manuel, Vice President-Operations
• Sandra A. Gardiner, CFO, Treasurer & Executive Vice President
• David Danitz, Senior Vice President-Engineering
• Richard Nuccitelli, Chief Science Officer

What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?

2 employees have rated Pulse Biosciences CEO Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among Pulse Biosciences' employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Pulse Biosciences' key competitors?

Some companies that are related to Pulse Biosciences include Glaukos (GKOS), Procept BioRobotics (PRCT), Silk Road Medical (SILK), Inovio Pharmaceuticals (INO), Paragon 28 (FNA), Atrion (ATRI), Pulmonx (LUNG), Cerus (CERS), OrthoPediatrics (KIDS), Alphatec (ATEC), LeMaitre Vascular (LMAT), Sight Sciences (SGHT), AngioDynamics (ANGO), Treace Medical Concepts (TMCI) and Bioventus (BVS).
View all of PLSE's competitors.

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA), Portola Pharmaceuticals (PTLA), (CGC), Enphase Energy (ENPH) and Novavax (NVAX).

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an initial public offering on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (2.85%), Granahan Investment Management Inc. MA (1.24%), Geode Capital Management LLC (0.84%), M&G Investment Management Ltd. (0.22%), Griffin Asset Management Inc. (0.21%) and Bank of New York Mellon Corp (0.13%).
View institutional ownership trends for Pulse Biosciences.

Which institutional investors are selling Pulse Biosciences stock?

PLSE stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Two Sigma Investments LP, BlackRock Inc., California State Teachers Retirement System, and Two Sigma Advisers LP.
View insider buying and selling activity for Pulse Biosciences or view top insider-selling stocks.

Which institutional investors are buying Pulse Biosciences stock?

PLSE stock was purchased by a variety of institutional investors in the last quarter, including Granahan Investment Management Inc. MA, M&G Investment Management Ltd., Citadel Advisors LLC, New York State Common Retirement Fund, Geode Capital Management LLC, SG Americas Securities LLC, Advisor Group Holdings Inc., and Metropolitan Life Insurance Co NY.
View insider buying and selling activity for Pulse Biosciences or or view top insider-buying stocks.

How do I buy shares of Pulse Biosciences?

Shares of PLSE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $19.99.

How much money does Pulse Biosciences make?

Pulse Biosciences has a market capitalization of $592.32 million. The company earns $-49.85 million in net income (profit) each year or ($2.34) on an earnings per share basis.

How many employees does Pulse Biosciences have?

Pulse Biosciences employs 95 workers across the globe.

What is Pulse Biosciences' official website?

The official website for Pulse Biosciences is www.pulsebiosciences.com.

Where are Pulse Biosciences' headquarters?

Pulse Biosciences is headquartered at 3957 POINT EDEN WAY, HAYWARD CA, 94545.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The company can be reached via phone at (510) 906-4600 or via email at [email protected].